C-MER Eye Care (03309) Repurchases 1.43 Million Shares Over Five Trading Days

C-MER Medical (03309) announced that, as of the date of this announcement, the company has repurchased 1.43 million shares from the market within the last five trading days under the repurchase mandate, at a total cost of HK$5.3 million (excluding brokerage commissions, stamp duties, and other expenses). The highest price paid per repurchased share was HK$3.82, while the lowest price was HK$3.61. The company will subsequently cancel the repurchased shares.